124 related articles for article (PubMed ID: 20515614)
1. Lactococcus lactis: from the dairy industry to antigen and therapeutic protein delivery.
Bahey-El-Din M; Gahan CG
Discov Med; 2010 May; 9(48):455-61. PubMed ID: 20515614
[TBL] [Abstract][Full Text] [Related]
2. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.
Steidler L; Neirynck S; Huyghebaert N; Snoeck V; Vermeire A; Goddeeris B; Cox E; Remon JP; Remaut E
Nat Biotechnol; 2003 Jul; 21(7):785-9. PubMed ID: 12808464
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
4. Heterologous protein production and delivery systems for Lactococcus lactis.
Nouaille S; Ribeiro LA; Miyoshi A; Pontes D; Le Loir Y; Oliveira SC; Langella P; Azevedo V
Genet Mol Res; 2003 Mar; 2(1):102-11. PubMed ID: 12917806
[TBL] [Abstract][Full Text] [Related]
5. Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10.
Huyghebaert N; Vermeire A; Neirynck S; Steidler L; Remaut E; Remon JP
Eur J Pharm Biopharm; 2005 Aug; 60(3):349-59. PubMed ID: 15927456
[TBL] [Abstract][Full Text] [Related]
6. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug delivery by genetically modified Lactococcus lactis.
Steidler L; Rottiers P
Ann N Y Acad Sci; 2006 Aug; 1072():176-86. PubMed ID: 17057198
[TBL] [Abstract][Full Text] [Related]
8. Actobiotics as a novel method for cytokine delivery.
Steidler L; Rottiers P; Coulie B
Ann N Y Acad Sci; 2009 Dec; 1182():135-45. PubMed ID: 20074282
[TBL] [Abstract][Full Text] [Related]
9. Normal flora: living vehicles for non-invasive protein drug delivery.
Shao J; Kaushal G
Int J Pharm; 2004 Nov; 286(1-2):117-24. PubMed ID: 15501008
[TBL] [Abstract][Full Text] [Related]
10. Targeting diseases with genetically engineered Lactococcus lactis and its course towards medical translation.
Villatoro-Hernandez J; Montes-de-Oca-Luna R; Kuipers OP
Expert Opin Biol Ther; 2011 Mar; 11(3):261-7. PubMed ID: 21204744
[TBL] [Abstract][Full Text] [Related]
11. Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization.
Audouy SA; van Roosmalen ML; Neef J; Kanninga R; Post E; van Deemter M; Metselaar H; van Selm S; Robillard GT; Leenhouts KJ; Hermans PW
Vaccine; 2006 Jun; 24(26):5434-41. PubMed ID: 16757068
[TBL] [Abstract][Full Text] [Related]
12. Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix.
Kim TW; Igimi S; Kajikawa A; Kim HY
J Appl Microbiol; 2008 Jun; 104(6):1636-43. PubMed ID: 18298534
[TBL] [Abstract][Full Text] [Related]
13. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine.
Raha AR; Varma NR; Yusoff K; Ross E; Foo HL
Appl Microbiol Biotechnol; 2005 Jul; 68(1):75-81. PubMed ID: 15635459
[TBL] [Abstract][Full Text] [Related]
14. A food-grade delivery system for Lactococcus lactis and evaluation of inducible gene expression.
Simões-Barbosa A; Abreu H; Silva Neto A; Gruss A; Langella P
Appl Microbiol Biotechnol; 2004 Jul; 65(1):61-7. PubMed ID: 14758518
[TBL] [Abstract][Full Text] [Related]
15. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
16. Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis.
Yam KK; Pouliot P; N'diaye MM; Fournier S; Olivier M; Cousineau B
Vaccine; 2008 May; 26(22):2689-99. PubMed ID: 18436352
[TBL] [Abstract][Full Text] [Related]
17. Lactococcus lactis as a cell factory for delivery of therapeutic proteins.
Bahey-El-Din M; Gahan CG; Griffin BT
Curr Gene Ther; 2010 Feb; 10(1):34-45. PubMed ID: 20156189
[TBL] [Abstract][Full Text] [Related]
18. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.
Bermúdez-Humarán LG; Cortes-Perez NG; Ah-Leung S; Lefèvre F; Yang G; Pang Q; Wu C; Zeng Y; Adel-Patient K; Langella P
J Mol Microbiol Biotechnol; 2008; 14(1-3):80-9. PubMed ID: 17957114
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
